Real-time enrollment status for this hematological malignancy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT03850366 |
| Recruiting Status | Recruiting |
| Condition | Hematological Malignancy |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Henry Ford Health System |
| Last Updated on CT.gov | February 24, 2026 (Feb 24, 2026) |
As of July 13, 2026: Clinical trial NCT03850366 is currently recruiting participants. This clinical trial study for hematological malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by Henry Ford Health System. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03850366 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03850366 was last updated Feb 24, 2026 (February 24, 2026). HelloStudys verifies this status automatically.